Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09FGW
|
|||
Drug Name |
Pyrimidinyl compound 4
|
|||
Synonyms |
PMID26293650-Compound-39
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H20N6O
|
|||
Canonical SMILES |
C1CCN(C1)C2=C(C=C(C=C2)C3=NC(=NC=C3)NC4=CC5=C(C=C4)NC(=O)C5)C#N
|
|||
InChI |
1S/C23H20N6O/c24-14-17-11-15(3-6-21(17)29-9-1-2-10-29)20-7-8-25-23(28-20)26-18-4-5-19-16(12-18)13-22(30)27-19/h3-8,11-12H,1-2,9-10,13H2,(H,27,30)(H,25,26,28)
|
|||
InChIKey |
DHPSFJYFPJRCTN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | NF-kappa-B-activating kinase (TBK1) | Target Info | Inhibitor | [1] |
Target's Patent Info | NF-kappa-B-activating kinase (TBK1) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | TBK1 inhibitors: a review of patent literature (2011 - 2014).Expert Opin Ther Pat. 2015;25(12):1385-96. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.